Valacyclovir
NDC 85766-270, Valacyclovir, tablet, from Sportpharm LLC.
- Product NDC
- 85766-270
- Status
- Listed
- Labeler
- Sportpharm LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209553
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85766-270 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- VALACYCLOVIR HYDROCHLORIDE500 mg/1
Pharmacologic classes
DNA Polymerase Inhibitors [MoA]; Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Nucleoside Analog [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85766-270-02 | 85766027002 | 2 TABLET in 1 BOTTLE (85766-270-02) |
| 85766-270-04 | 85766027004 | 4 TABLET in 1 BOTTLE (85766-270-04) |
| 85766-270-06 | 85766027006 | 6 TABLET in 1 BOTTLE (85766-270-06) |
| 85766-270-07 | 85766027007 | 7 TABLET in 1 BOTTLE (85766-270-07) |
| 85766-270-10 | 85766027010 | 10 TABLET in 1 BOTTLE (85766-270-10) |
| 85766-270-14 | 85766027014 | 14 TABLET in 1 BOTTLE (85766-270-14) |
| 85766-270-15 | 85766027015 | 15 TABLET in 1 BOTTLE (85766-270-15) |
| 85766-270-20 | 85766027020 | 20 TABLET in 1 BOTTLE (85766-270-20) |
| 85766-270-30 | 85766027030 | 30 TABLET in 1 BOTTLE (85766-270-30) |
| 85766-270-60 | 85766027060 | 60 TABLET in 1 BOTTLE (85766-270-60) |
| 85766-270-90 | 85766027090 | 90 TABLET in 1 BOTTLE (85766-270-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/14e479b1-8afd-4912-8f93-59b60a0868bc
Use it
Look up 85766-270 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85766-270 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85766-270. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.